Suppr超能文献

食管之外的嗜酸性粒细胞:非嗜酸性食管炎嗜酸性胃肠道疾病综述

Eosinophils Beyond the Esophagus: A Review of Non-EoE Eosinophilic Gastrointestinal Diseases.

作者信息

Lam Angela Y, Gonsalves Nirmala

机构信息

Department of Gastroenterology and Hepatology, Kaiser Permanente San Francisco, San Francisco, California.

Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

出版信息

Gastroenterol Hepatol (N Y). 2025 Aug;21(8):511-519.

Abstract

For eosinophilic esophagitis (EoE), the most well researched of the eosinophilic gastrointestinal diseases (EGIDs), there is a plethora of knowledge for its diagnosis and management; however, much less guidance is available for the non-EoE EGIDs. Efforts have been made to characterize the clinical features, epidemiology, diagnosis, and natural history of EGIDs, as the frequency of the non-EoE EGIDs has continued to rise. The diagnosis of the different non-EoE EGIDs, eosinophilic gastritis, enteritis, and colitis, can be challenging because of their rarity and heterogeneous presentations which can lead to delayed diagnosis and poor health-related quality of life in affected patients. Guidelines for histologic evaluation and diagnostic criteria for non-EoE EGID are actively being developed. Effective management of non-EoE EGIDs is possible with currently available assessments and therapies, with more treatments on the horizon, highlighting the need for improved understanding of non-EoE EGIDs. This article will review the diagnosis and management of the non-EoE EGIDs, focusing on the consensus nomenclature, nuances in diagnosis, and management options.

摘要

对于嗜酸性粒细胞性食管炎(EoE),这是研究最为充分的嗜酸性粒细胞性胃肠道疾病(EGIDs),其诊断和管理方面已有大量知识;然而,对于非EoE的EGIDs,可用的指导却少得多。随着非EoE的EGIDs发病率持续上升,人们已努力对EGIDs的临床特征、流行病学、诊断及自然史进行描述。不同的非EoE的EGIDs,即嗜酸性粒细胞性胃炎、肠炎和结肠炎,其诊断可能具有挑战性,因为它们罕见且表现多样,这可能导致诊断延迟以及受影响患者的健康相关生活质量较差。目前正在积极制定非EoE的EGID的组织学评估指南和诊断标准。利用现有的评估和治疗方法,对非EoE的EGIDs进行有效管理是可行的,未来还会有更多治疗方法出现,这凸显了加强对非EoE的EGIDs理解的必要性。本文将回顾非EoE的EGIDs的诊断和管理,重点关注共识命名法、诊断细微差别和管理选项。

相似文献

4
Eosinophil Involvement Outside the Esophagus in Eosinophilic Esophagitis.
Clin Gastroenterol Hepatol. 2024 Jul;22(7):1531-1534.e2. doi: 10.1016/j.cgh.2023.12.004. Epub 2023 Dec 15.
5
Eosinophilic gastrointestinal disorders and the role for the epithelium in pathogenesis and treatment.
Curr Opin Pediatr. 2024 Dec 1;36(6):668-673. doi: 10.1097/MOP.0000000000001406. Epub 2024 Sep 20.
7
Eosinophilic Gastritis and Enteritis Are Increased in Families With Eosinophilic Esophagitis.
Am J Gastroenterol. 2023 Feb 1;118(2):263-268. doi: 10.14309/ajg.0000000000002021. Epub 2022 Sep 21.
8
Initial Validation of the Eosinophilic Gastritis and Gastroenteritis Quality of Life Scale.
Gastro Hep Adv. 2025 Jan 25;4(5):100627. doi: 10.1016/j.gastha.2025.100627. eCollection 2025.

本文引用的文献

1
Initial Validation of the Eosinophilic Gastritis and Gastroenteritis Quality of Life Scale.
Gastro Hep Adv. 2025 Jan 25;4(5):100627. doi: 10.1016/j.gastha.2025.100627. eCollection 2025.
2
Gastrointestinal Tissue Eosinophil Quantification in Healthy Adult Volunteers.
Gastroenterology. 2025 Jul;169(1):158-160.e2. doi: 10.1053/j.gastro.2025.02.011. Epub 2025 Feb 25.
3
The Natural History of Eosinophilic Gastrointestinal Diseases Is Influenced by Age of Onset and Location of Involvement.
Am J Gastroenterol. 2024 Sep 1;119(9):1813-1820. doi: 10.14309/ajg.0000000000002869. Epub 2024 May 16.
4
Clinical and histologic remission achieved with upadacitinib in a patient with refractory eosinophilic gastritis and duodenitis.
J Allergy Clin Immunol Pract. 2024 Jun;12(6):1649-1651. doi: 10.1016/j.jaip.2024.02.031. Epub 2024 Feb 27.
5
Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis.
J Pediatr Gastroenterol Nutr. 2024 Jan;78(1):122-152. doi: 10.1097/MPG.0000000000003877. Epub 2023 Jul 4.
6
Natural Histories and Disease Complications in a Cohort of 151 Children With Gastric or Duodenal Eosinophilia.
Am J Gastroenterol. 2024 Jul 1;119(7):1298-1308. doi: 10.14309/ajg.0000000000002644. Epub 2024 Jan 4.
7
Dupilumab Can Induce Remission of Eosinophilic Gastritis and Duodenitis: A Retrospective Case Series.
Clin Transl Gastroenterol. 2024 Jan 1;15(1):e00646. doi: 10.14309/ctg.0000000000000646.
8
Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial.
J Allergy Clin Immunol. 2023 Sep;152(3):676-688. doi: 10.1016/j.jaci.2023.05.024. Epub 2023 Jul 18.
9
Dupilumab treatment of eosinophilic gastrointestinal disease in an adolescent.
Pediatr Allergy Immunol. 2023 Jun;34(6):e13973. doi: 10.1111/pai.13973.
10
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Gastroenterol Hepatol. 2023 Sep;8(9):803-815. doi: 10.1016/S2468-1253(23)00145-0. Epub 2023 Jun 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验